Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Champions Oncology (CSBR) over the last 11 years, with Q4 2025 value amounting to $708000.0.

  • Champions Oncology's Treasury Shares changed 0.0% to $708000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $708000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $708000.0 for FY2025, which is 0.0% changed from last year.
  • As of Q4 2025, Champions Oncology's Treasury Shares stood at $120300.0, which was down 2.74% from $120333.0 recorded in Q3 2025.
  • Champions Oncology's 5-year Treasury Shares high stood at $120333.0 for Q4 2023, and its period low was $14422.0 during Q2 2023.
  • Its 3-year average for Treasury Shares is $110256.6, with a median of $120333.0 in 2023.
  • Over the last 5 years, Champions Oncology's Treasury Shares had its largest YoY gain of 85675.68% in 2024, and its largest YoY loss of 0.0% in 2024.
  • Champions Oncology's Treasury Shares (Quarter) stood at $708000.0 in 2023, then changed by 0.0% to $708000.0 in 2024, then changed by 0.0% to $708000.0 in 2025.
  • Its last three reported values are $708000.0 in Q4 2025, $708000.0 for Q3 2025, and $708000.0 during Q2 2025.